Scholarlink

Background <p>To evaluate the independent and combined effects of mean blood glucose (MBG) and glycemic variability (GV) on 28-day mortality in older adults with acute myocardial infarction (AMI).</p> Methods <p>A retrospective cohort analysis was conducted using the Medical Information Mart for Intensive Care IV (MIMIC-IV) database, focusing on AMI patients aged ≥ 65 years. Participants were stratified into age cohorts: 65–75, 75–85, and ≥ 85 years. MBG and GV were derived from all glucose readings throughout the ICU stay. The primary outcome was 28-day mortality, and hypoglycemia was a secondary outcome. Cox regression with risk-adjusted restricted cubic splines was applied to examine associations.</p> Results <p>Among 1,242 older adults (mean age 77.3 ± 7.5 years), the mean MBG was 147.1 ± 43.1&#xa0;mg/dL and median GV was 33.5 (IQR 20.7–55.0) mg/dL. During follow-up, 295 participants (23.8%) died within 28 days. Multivariable analysis showed that each 10&#xa0;mg/dL increase in MBG and GV was linked to a 17% (Model 3: HR = 1.17; 95% CI, 1.13–1.20) and 6% (HR = 1.06; 95% CI, 1.03–1.08) higher mortality risk, respectively (both <i>p</i> &lt; 0.001). Further analysis, using the low MBG/low GV group as the reference, revealed distinct mortality risk patterns. The high MBG/low GV subgroup exhibited the strongest association with mortality, showing a 5.77-fold increased risk (HR = 5.77; 95% CI, 3.36–9.92; <i>p</i> &lt; 0.001). These associations remained consistent in both diabetic and non-diabetic subgroups (<i>p</i> &lt; 0.001).</p> Conclusions <p>Elevated mean blood glucose and glycemic variability independently predicted 28-day mortality in older adults with acute myocardial infarction. Critically, sustained hyperglycemia demonstrated greater clinical detriment than acute glucose fluctuations, necessitating risk-stratified glycemic protocols prioritizing MBG control in this vulnerable population.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Independent and combined effects of mean blood glucose and glycemic variability on 28-day mortality in older acute myocardial infarction patients: a MIMIC-IV cohort study

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年12月6日

查看全文
  • Jun Zhou,
  • Xiaomei Deng,
  • Peng Zhou,
  • Xinlin Luo,
  • Hao Li,
  • Xiaoyun Fan

摘要

Background

To evaluate the independent and combined effects of mean blood glucose (MBG) and glycemic variability (GV) on 28-day mortality in older adults with acute myocardial infarction (AMI).

Methods

A retrospective cohort analysis was conducted using the Medical Information Mart for Intensive Care IV (MIMIC-IV) database, focusing on AMI patients aged ≥ 65 years. Participants were stratified into age cohorts: 65–75, 75–85, and ≥ 85 years. MBG and GV were derived from all glucose readings throughout the ICU stay. The primary outcome was 28-day mortality, and hypoglycemia was a secondary outcome. Cox regression with risk-adjusted restricted cubic splines was applied to examine associations.

Results

Among 1,242 older adults (mean age 77.3 ± 7.5 years), the mean MBG was 147.1 ± 43.1 mg/dL and median GV was 33.5 (IQR 20.7–55.0) mg/dL. During follow-up, 295 participants (23.8%) died within 28 days. Multivariable analysis showed that each 10 mg/dL increase in MBG and GV was linked to a 17% (Model 3: HR = 1.17; 95% CI, 1.13–1.20) and 6% (HR = 1.06; 95% CI, 1.03–1.08) higher mortality risk, respectively (both p < 0.001). Further analysis, using the low MBG/low GV group as the reference, revealed distinct mortality risk patterns. The high MBG/low GV subgroup exhibited the strongest association with mortality, showing a 5.77-fold increased risk (HR = 5.77; 95% CI, 3.36–9.92; p < 0.001). These associations remained consistent in both diabetic and non-diabetic subgroups (p < 0.001).

Conclusions

Elevated mean blood glucose and glycemic variability independently predicted 28-day mortality in older adults with acute myocardial infarction. Critically, sustained hyperglycemia demonstrated greater clinical detriment than acute glucose fluctuations, necessitating risk-stratified glycemic protocols prioritizing MBG control in this vulnerable population.